Skip to main content
Clinical Trials/NCT00770614
NCT00770614
Completed
Phase 4

Hydration and Contrast-Induced Nephropathy in Primary Angioplasty. A Randomized, Placebo Controlled, Trial.

Ospedale Misericordia e Dolce1 site in 1 country450 target enrollmentMarch 2004

Overview

Phase
Phase 4
Intervention
sodium bicarbonate solution
Conditions
Contrast Induced Nephropathy
Sponsor
Ospedale Misericordia e Dolce
Enrollment
450
Locations
1
Primary Endpoint
Absolute increase of at least 0.5 mg/dl from the baseline value in serum creatinine concentration or a relative increase ≥ 25% over baseline serum creatinine within 5 days after contrast agent administration
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to determine whether hydration with sodium bicarbonate is more effective than hydration with sodium chloride to prevent contrast induced nephropathy in patients undergoing Primary Coronary Intervention for Acute ST Elevation Myocardial Infarction.

Registry
clinicaltrials.gov
Start Date
March 2004
End Date
December 2008
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ospedale Misericordia e Dolce
Responsible Party
Principal Investigator
Principal Investigator

Mauro Maioli

MD

Ospedale Misericordia e Dolce

Eligibility Criteria

Inclusion Criteria

  • patients with Acute ST Elevation Myocardial Infarction submitted to Primary Intervention

Exclusion Criteria

  • refusal to consent
  • previous contrast exposure within 72 hours

Arms & Interventions

1

Sodium Bicarbonate (154 mEq/L in dextrose and H2O) 3 mL/kg for 1 hour before contrast medium, followed by an infusion of 1 mL/kg/h for 12 hours after the procedure

Intervention: sodium bicarbonate solution

2

Isotonic Saline (0.9% sodium chloride) 1 mL/kg/h for 12 hours after the procedure

Intervention: Isotonic saline

3

Placebo

Intervention: Placebo

Outcomes

Primary Outcomes

Absolute increase of at least 0.5 mg/dl from the baseline value in serum creatinine concentration or a relative increase ≥ 25% over baseline serum creatinine within 5 days after contrast agent administration

Time Frame: within 5 days after contrast exposure

Secondary Outcomes

  • Adverse clinical events within 1 month, including in-hospital death and need for dialysis or hemofiltration(1 month)

Study Sites (1)

Loading locations...

Similar Trials